MAPK3 and glioblastoma: Yokukansan downregulates COX-2 expression and suppresses ERK1/2 and p38 MAPK (mitogen-activated protein kinase) phosphorylation and NF-κB nuclear translocation, induced by substance P, in U-373MG glioblastoma cells [67].